课题基金 / 基金详情

Genetics of Renal Disease in African Americans

Genetics of Renal Disease in African Americans
非裔美国人肾病遗传学
批准号:
8175295
负责人:
Cheryl Winkler
金额:
$78.65万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Cheryl Winkler的其他基金

相似基金

相关文献

中文摘要
翻译
慢性肾脏疾病,影响超过2600万美国人,经常导致肾衰竭,需要透析或肾移植。每年有超过10万人患上肾衰竭,近50万人接受透析或肾移植,每年花费300亿美元。 需要透析或肾脏替代以存活的肾衰竭的三个主要原因是2型糖尿病、高血压和肾小球硬化症。非裔美国人患终末期肾病(ESRD)的可能性是白色人的3-4倍。FSGS是成人原发性肾病综合征的主要原因,也是儿童终末期肾病(ESRD)的主要原因。FSGS是一种综合征,包括特发性变异和与肾单位数量减少、高血压和HIV-1感染相关的变异。非洲裔美国人患特发性FSGS的风险是正常人的4倍,患HIV相关FSGS的风险增加50至70倍,也称为HIV相关肾病(HIVAN)。HIVAN是非洲裔美国成年男性肾衰竭的第三大原因。 与NIDDK肾脏疾病科合作,从13个院外研究中心招募了患者。该研究包括活检证实的散发性FSGS或HIV-1相关肾病(HIVAN)病例,以及活检证实的塌陷性肾小球硬化症和919名供体对照。超过60%的终末期肾病与糖尿病和高血压有关,约30%与肾小球病有关,主要是由于FSGS。我们还进行了合作,以研究宿主遗传因素在肾脏疾病的其他病因中的作用(例如,镰状细胞性贫血、肾炎、先兆子痫、狼疮、糖尿病和高血压)。正在进行的一项主要研究是确定参加非裔美国人肾脏病和高血压(AASK)试验的非裔美国人高血压患者中蛋白尿和终末期肾病(ESRD)的遗传预测因子。 足细胞中表达的结构蛋白被假定在影响液压流和蛋白质从血浆空间进入肾脏中的尿空间中起关键作用。足细胞表达的结构基因突变与常染色体隐性和显性孟德尔局灶节段性肾小球硬化症相关,通常发病较早,但相同基因的变异与发病年龄较晚的特发性FSGS无关。我们最近报道,在Chr 22区域携带MYH 9的风险等位基因与FSGS、HIVAN和非糖尿病终末期肾病密切相关。然而,即使经过广泛的搜索,因果等位基因没有确定。 最近选择的22号染色体区域包含MYH 9和APOL 1:2008年,我们在22号染色体上发现了一个与HIV相关肾病以及其他严重形式肾病风险增加相关的区域。肾脏风险等位基因在非洲裔美国人中很常见,但在欧洲人中很少见,从而为主要的健康差异提供了遗传基础。使用来自人类基因组多样性小组(HGDP)的DNA样本,我们表明,在尼日利亚伊巴丹的约鲁巴人中,Chr 22 MYH 9区域最近受到选择,但在其他非洲人群中没有。我们假设MYH 9肾脏风险等位基因可能追踪邻近APOL 1基因的变异。APOL 1裂解布氏锥虫,但不裂解锥虫B。rhodensiense或gambiense。都是结核病罗得西亚锥虫和冈比亚锥虫编码解除APOL 1的锥虫溶解活性的因子。 在一项国际合作中,我们使用人群方法和1000个基因组计划的结果,在隐性模型中鉴定了APOL 1基因中与特发性FSGS和非糖尿病ESRD(OR 15-40)密切相关的两种突变。APOL 1与MYH 9仅相距14 kb,MYH 9和APOL 1风险等位基因出现在相同的单倍型上,这是由于西非人最近对这些等位基因的选择。血浆有效地溶解了T. b。即使在大于1000的滴度下,也能检测到罗得西亚杆菌,这表明携带一种或另一种锥虫溶解突变的供体血浆可能被证明是治疗结核病的成本有效的方法。罗得西亚语虽然APOL 1突变在携带者中提供针对致命病原体的保护,但是对于锥虫溶解突变的纯合子和复杂杂合子的个体更容易患肾脏疾病。对原发性FSGS和高血压引起的终末期肾病的影响非常强。我们已经证明MYH 9风险等位基因与以肾小球损伤为特征的广泛的肾脏疾病相关,OR在4-7范围内。APOL 1突变具有更强的影响,使其成为迄今为止发现的常见疾病的最强风险因素。通过揭示特定的遗传病变是几乎所有FSGS的基础,并且是非糖尿病ESRD的重要组成部分,这些发现从根本上改变了对这些疾病的理解,并揭示了主要健康差异的基础。
英文摘要
Chronic kidney disease, affecting over 26 million Americans, frequently leads to kidney failure requiring either dialysis or kidney transplant. Each year more than 100,000 individuals develop kidney failure and nearly 500,000 receive dialysis or kidney transplants at an annual cost of $30 billion dollars. The three leading causes of kidney failure requiring dialysis or kidney replacement for survival are type 2 diabetes, hypertension, and glomerulosclerosis. African Americans are 3-4 times more likely to develop end stage renal disease (ESRD) compared to their white counterparts. FSGS is the leading cause of primary nephritic syndrome in adults and the leading cause of end-stage renal disease (ESRD) in children. FSGS represents a syndrome that includes idiopathic variants and variants associated with reduced nephron numbers, hypertension, and HIV-1 infection. African-Americans are at a four-fold risk of developing idiopathic FSGS, and at a 50 to 70-fold increased risk for HIV-associated FSGS, also known as HIV-associated nephropathy (HIVAN). HIVAN is the third leading cause of kidney failure in African American adult men. In collaboration with the Kidney Disease Section, NIDDK, patients have been enrolled from 13 extramural sites. The study comprises biopsy-proven sporadic FSGS or HIV-1-associated nephropathy (HIVAN) cases with biopsy-proven collapsing glomerulosclerosis and 919 donor controls. More than 60% of end stage kidney disease is associated with diabetes and hypertension, and approximately 30% with glomerulopathies, mainly due to FSGS. We have have also entered into collaborations to investigate the role of host genetic factors in other etiologies of kidney disease (e.g., sickle cell anemia nephritis, pre-elampsia, lupus, diabetes, and hypertension). A major on-going investigation is to determine genetic predictors of proteinuria and endstage renal disease (ESRD) in African Americans with hypertension enrolled in the African American Kidney Disease and Hypertension (AASK) Trial. Structural proteins expressed in podocytes are postulated to play a critical role in influencing hydraulic flow and protein exit from the plasma space into the urinary space in the kidney. Mutations in podocyte-expressed structural genes have been associated with both autosomal recessive and dominant Mendelian focal segmental glomerulosclerosis, generally with early onset, but variants in the same genes have not been associated with idiopathic FSGS with generally later age of onset. We recently reported that risk alleles in the Chr 22 region harboring MYH9 were strongly associated with FSGS, HIVAN, and non-diabetic end stage renal disease. However, even after extensive searching, causal alleles were not identified. Accomplishments Chromosome 22 region harboring MYH9 and APOL1 under recent selection: In 2008 we identified a region on Chr 22 associated with increased risk of HIV-associated nephropathy as well as other severe forms of kidney disease. The renal risk alleles were frequent in African Americans but rare in Europeans thereby providing a genetic basis for a major health disparity. Using DNA samples from the Human Genome Diversity Panel (HGDP) we showed that the Chr 22 MYH9 region was under recent selection in Yoruba from Ibadan, Nigeria but not in other African populations. We hypothesized that the MYH9 renal risk alleles might tracking variants in the adjacent APOL1 gene. APOL1 lyses Trypanosome brucei brucei but not Trypanosome b. rhodensiense or gambiense. Both T.b. rhodesiense and T.b.gambiense encode a factor that disarms the trypanolytic activity of APOL1. In an international collaboration, we used population approaches and the results from the 1000 Genomes Project to identify two mutations in the APOL1 gene that were strongly associated with idiopathic FSGS and non-diabetic ESRD (OR 15-40) in a recessive model. APOL1 is only 14 kb from MYH9 and the MYH9 and APOL1 risk alleles occur on the same haplotypes due to the recent selection in west Africans on these alleles. The plasma effectively lysed T.b. rhodesiense even at titers greater than 1000 suggesting that donor plasma harboring one or the other trypanolytic mutation might prove to be a cost-effective treatment for T.b. rhodesiense. While APOL1 mutations provide protection against a lethal pathogen in carriers individuals who are homozygotes and complex heterozygotes for the trypanolytic mutations are more vulnerable to kidney disease. The effects are extremely strong for idiopathic FSGS and end stage renal disease attributed to hypertension. We have shown that MYH9 risk alleles are associated with a broad range of kidney disease characterized by glomerular injury with OR in the 4-7 range. The APOL1 mutations have even stronger effects, making these the strongest risk factors discovered to date for a common disease. By revealing that a specific genetic lesion is fundamental to almost all FSGS, and a significant fraction of non-diabetic ESRD, these findings have fundamentally changed the understanding of these diseases, and uncovered the basis of a major health disparity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetics of Renal Disease in African Americans
  • 批准号:
    7965194
  • 项目类别:
  • 资助金额:
    $97.83万
  • 财政年份:
    --
  • 负责人:
    Cheryl Winkler
  • 依托单位:
Genetics of Renal Disease in African Americans
  • 批准号:
    8552639
  • 项目类别:
  • 资助金额:
    $51.13万
  • 财政年份:
    --
  • 负责人:
    Cheryl Winkler
  • 依托单位:
Genetics of Complex Diseases and Health Disparities
  • 批准号:
    9556246
  • 项目类别:
  • 资助金额:
    $65.37万
  • 财政年份:
    --
  • 负责人:
    Cheryl Winkler
  • 依托单位:
Identification of Genetic Factors Associated with Infectious Diseases
  • 批准号:
    9556253
  • 项目类别:
  • 资助金额:
    $43.58万
  • 财政年份:
    --
  • 负责人:
    Cheryl Winkler
  • 依托单位:
海外基金